The UK's National Institute for Health and Clinical Excellence (NICE) has announced the establishment of the new independent Primary Care Quality and Outcomes Framework (QOF) Indicator Advisory Committee.
The Advisory Committee is made up of 29 members with a range of expertise from across primary care and includes three regional directors of public health, nine general practitioners, seven GP academics, three lay representatives and seven other health care professionals from a range of disciplines; one position on the committee remains vacant to be filled at a later date. The committee, whose membership is drawn from the four UK nations, is responsible for reviewing existing QOF indicators and recommending new ones before producing a national "menu" of approved indicators which will be made available through the NICE web site.
The Advisory Committee's first meeting was chaired by Colin Hunter who will work closely with the NICE QOF team and the consortium (consisting of the National Primary Care Research and Development Centre/York Health Economics Consortium (YHEC)/Royal College of General Practitioners (RCGP)) commissioned by the NICE to develop and review indicators on clinical or public health topics recommended by the Advisory Committee.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze